Tue, Nov 05, 2024 | Updated 09:56 IST
Dr PBN Prasad to hold charge as DCGI on temporary basis
Feb 15, 2023
Dr PBN Prasad will hold the charge of the post of Drug Controller of India from February 16 to 28 this year or until...
Cabinet clears Rajeev Singh Raghuvanshi's name as new DCGI
Feb 22, 2023
Dr Singh is scheduled to take charge from 28th February. Till then, Dr PBN Prasad has been appointed to the post on a temporary...
After Sri Lanka, Thailand waives visas for Indian tourists
Oct 31, 2023
The announcement was made following a decision by the Thai Cabinet, which agreed to exempt tourists from India and Taiwan from requiring an entry...
DCGI recommends Covovax as heterologous booster dose
Jan 12, 2023
The Central drug regulatory authority Drugs Controller General of India (DCGI) has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as...
Drugs Controller General of India bans all charges, except supply, processing costs on blood units
Jan 04, 2024
The Drugs Controller General of India (DCGI) has waived all charges except processing costs on blood units.
Zydus Cadila submits additional data to DCGI: Sources
Jul 27, 2021
New Delhi [India], July 27 : Ahmedabad-based Zydus Cadila has submitted additional data related to immunogenicity and safety to India's drug regulator Drugs Controller...
Zydus Lifesciences gets DCGI approval for Oxemia drug
Mar 07, 2022
DCGI grants conditional market approval for Covaxin, Covishield
Jan 27, 2022
DCGI approves Themis Medicare's VIRALEX for Covid-19 treatment
Mar 05, 2022
DCGI chief Venugopal Somani's tenure extended by 3 months
Aug 17, 2022
DCGI approves Keytruda for treatment of cervical cancer: MSD
Jan 24, 2023
Glenmark responds to DCGI letter seeking clarification on Fabiflu
Jul 21, 2020
Related Videos
No Result Found